Abstract
Myocardial Infarction (MI) an integral part of Acute Coronary Syndrome (ACS) occurs due to Atherosclerotic narrowing of the Coronary blood vessels. ACS being one of the major cardiovascular diseases (CVDs) has led to a significant amount of mortality & morbidity. The post-myocardial infarction period greatly impacted the physical; psychological; social; emotional; and occupational well-being. Cardiac rehabilitation (CR) helps by addressing these immediate effects & also improves long-term well-being and overall quality of life. The benefits of CR include enhanced exercise capacity, risk factor reduction, improved quality of life (QOL), and reduced mortality and hospital readmission. We used a systematic literature review (SLR) approach in his article to provide a global overview of the cutting edge offered by CR in the post-MI phase. We reviewed 33 articles from journals of good repute published between 2013 and August 15, 2023, focusing on six selected papers for in-depth analysis. The analysis was focused on factors such as positive outcomes of CR, and the effects of CR in post-myocardial infarction. Even though there is a lack of statistically significant evidence for the benefits of CR; Meta-analyses confirm its positive impact on cardiovascular outcomes, such as decreased mortality, cardiac events, and hospital Readmissions. There is still a need for ongoing research to enhance the understanding of its mechanisms and statistically prove its effectiveness. As CR continues to evolve, referral and participation in CR should be increased as it improves overall health and well-being.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
First author: Raghu Ram Shanmukh Nemani, MBBS [nemanishanmukh{at}gmail.com]
Co-authors: Bala Sushritha Gade, MBBS [balasushritha.gade{at}gmail.com], Dedeepya Panchumarthi, MBBS [panchumarthidedeepya{at}gmail.com], Sasidhar Reddy Bathula, MBBS [sasidhareddybathula{at}gmail.com].
Data Availability
All data produced in the present work are contained in the manuscript
Abbreviations used
- (MI)
- Myocardial Infarction
- (AMI)
- Acute myocardial infarction
- (ACS)
- Acute Coronary Syndrome
- (CVDs)
- Cardiovascular diseases
- (CR)
- Cardiac rehabilitation
- (QOL)
- Improved quality of life